Skip to content

PMCF 8 Year Results TRJ®

Prospective Non-Interventional Post Market Clinical Follow-up Study TRJ® - 8 Years Results

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04542174
Enrollment
25
Registered
2020-09-09
Start date
2020-09-10
Completion date
2021-09-26
Last updated
2022-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip, Follow-Up Study

Keywords

Trochanter retaining joint replacement

Brief summary

The intention of this Post Market Clinical Follow-Up study is to obtain mid-term results of the TRJ® endoprosthesis. Aim is to include those patients that have received a TRJ® Total Hip Arthroplasty in 2012 and already did participated in a clinical study taking place in 2014 to obtain 2 years results

Interventions

None listed

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients have received a TRJ® prosthesis in 2012 * Patient did participate in the 2 years results evaluation 2014 * Patient gave his written consent for study participation

Exclusion criteria

* patient is pregnant * patient \< 18 years

Design outcomes

Primary

MeasureTime frameDescription
Survival rate of the stemat follow-up examination approximately 8 years after primary interventionThe survival of the TRJ® stem prosthesis will be analyzed using the Kaplan-Meier. Isolated revisions of the inlay and / or of the acetabular components (with the stem being kept in place) are documented, but assessed separately.

Secondary

MeasureTime frameDescription
Harris Hip Score (HHS)at follow-up examination approximately 8 years after primary interventionThe Harris Hip Score (HHS) is one of the most used scores in total hip arthroplasty, mainly combining range of motion questions with questions regarding daily life activities.
Rate of Adverse and Serious Adverse Eventsat follow-up examination approximately 8 years after primary interventionAll Adverse Events (AE) / Serious Adverse Events (SAE) either observed during the follow-up examination, found in the patient file of the hospital or reported by the patient will be documented. Only those AE and SAE that could be related to the investigational product or the TRJ® Total Hip Arthroplasty procedure in 2012 are of interest.
Pain Assessmentat follow-up examination approximately 8 years after primary interventionPain will be measured with a Visual Analogue Scale (VAS), at rest and when walking on flat ground. The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain). The patient is asked to mark their current pain level on the line.
Radiological Outcome: Inlay wearat follow-up examination approximately 8 years after primary interventionInlay wear is assessed on AP x-rays of the cup and will be analysed according to the zones defined by DeLee and Charnley. Charnley and Gruen zones of the hip are distinct zones used in assessment of aseptic loosening in total hip joint replacements.
Radiological Outcome: Bony Osseointegration or conspicuous features of the cupat follow-up examination approximately 8 years after primary interventionBony Osseointegration or conspicuous features of the Cup are assessed on anterior-posterior x-rays of the cup and will be analysed according to the zones defined by DeLee and Charnley. Charnley and Gruen zones of the hip are distinct zones used in assessment of aseptic loosening in total hip joint replacements.
Hip Dysfunction and Osteoarthritis Outcome Score (HOOS)at follow-up examination approximately 8 years after primary interventionThe Hip Dysfunction and Osteoarthritis Outcome Score (HOOS) is a 40 items patient reported outcome score (PROM) designed specifically to evaluate the physical functionality of hip osteoarthritis patients. The HOOS offers 5 subgroups, each with 100 points as best result.
Radiological Outcome: Bone resorption at the medial stem neckat follow-up examination approximately 8 years after primary interventionBone Resorption is assessed on anterior-posterior and lateral x-rays of the stem
Radiological Outcome: Bone resorption at the Trochanter Majorat follow-up examination approximately 8 years after primary interventionBone Resorption is assessed on anterior-posterior and lateral x-rays of the stem
Radiological Outcome: Evaluation of bony osseointegration or conspicuous features of the stemat follow-up examination approximately 8 years after primary interventionBony Osseointegration or conspicuous features of the stem are assessed on anterior-posterior and lateral x-rays of the stem and will be analysed according to the zones defined by Gruen. Charnley and Gruen zones of the hip are distinct zones used in assessment of aseptic loosening in total hip joint replacements
Radiological Outcome: Heterotopic Ossificationat follow-up examination approximately 8 years after primary interventionBrooker classification divides heterotopic ossifications that form following total hip replacement to four classes. Class I: islands of bone within soft tissues around hip; Class II: bone spurs in pelvis or proximal end of femur leaving ≥1 cm between the opposing bone surfaces; Class III: bone spurs that extend from pelvis or the proximal end of femur, which reduce the space between the opposing bone surfaces to \<1cm; Class IV: ankylosis of the hip on x-ray
Radiological Outcome: Migration of the stem in mmat follow-up examination approximately 8 years after primary interventionMigration of the stem is assessed in \[mm\] relative to discharge x-rays

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026